Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Interleukin-1 Receptor Antagonist on Insulin Secretion in Subjects With Beta Cell Dysfunction

NCT01285232 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT01285232
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01285232 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Interleukin-1 Receptor Antagonist on Insulin Secretion in Subjects With Beta Cell Dysfunction
Lead sponsor
Radboud University Medical Center
Phase
Not applicable
Overall status
Unknown status
Start date
January 31, 2011
Completion date
December 31, 2012
Enrollment
16 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus type 2, glucose intolerance, impaired insulin secretion